Saudi Pharmaceutical Industries and Medical Appliances Corporation (2070.SR)
SAR 31.65
(-0.32%)
SAR 31.65
(-0.32%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 940 Million SAR | 25.94% |
| 2022 | 746.39 Million SAR | -22.77% |
| 2021 | 966.49 Million SAR | -5.3% |
| 2020 | 1.02 Billion SAR | 22.84% |
| 2019 | 830.8 Million SAR | -77.28% |
| 2018 | 3.65 Billion SAR | 4204.56% |
| 2017 | -89.08 Million SAR | 72.68% |
| 2016 | -326.06 Million SAR | -812.47% |
| 2015 | 45.76 Million SAR | 138.27% |
| 2014 | -119.57 Million SAR | -21.11% |
| 2013 | -98.73 Million SAR | 40.57% |
| 2012 | -166.13 Million SAR | 44.18% |
| 2011 | -297.63 Million SAR | 14.27% |
| 2010 | -347.17 Million SAR | -225.61% |
| 2009 | -106.62 Million SAR | -70.12% |
| 2008 | -62.67 Million SAR | 63.2% |
| 2007 | -170.32 Million SAR | -30.35% |
| 2006 | -130.66 Million SAR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 1.02 Billion SAR | 9.04% |
| 2024 Q2 | 1.18 Billion SAR | 15.5% |
| 2023 Q3 | 969.4 Million SAR | -7.91% |
| 2023 Q2 | 1.05 Billion SAR | 10.13% |
| 2023 Q1 | 955.76 Million SAR | 28.05% |
| 2023 Q4 | 940 Million SAR | -3.03% |
| 2023 FY | 940 Million SAR | 25.94% |
| 2022 Q4 | 746.39 Million SAR | -7.61% |
| 2022 FY | 746.39 Million SAR | -22.77% |
| 2022 Q1 | 1.08 Billion SAR | 12.09% |
| 2022 Q2 | 896.09 Million SAR | -17.28% |
| 2022 Q3 | 807.85 Million SAR | -9.85% |
| 2021 Q1 | 1.11 Billion SAR | 9.68% |
| 2021 FY | 966.49 Million SAR | -5.3% |
| 2021 Q3 | 1.08 Billion SAR | -4.65% |
| 2021 Q4 | 966.49 Million SAR | -10.85% |
| 2021 Q2 | 1.13 Billion SAR | 1.57% |
| 2020 Q4 | 1.02 Billion SAR | -2.52% |
| 2020 FY | 1.02 Billion SAR | 22.84% |
| 2020 Q2 | 1.02 Billion SAR | 10.81% |
| 2020 Q3 | 1.04 Billion SAR | 2.51% |
| 2020 Q1 | 921.6 Million SAR | 10.93% |
| 2019 Q1 | 789.26 Million SAR | -78.42% |
| 2019 FY | 830.8 Million SAR | -77.28% |
| 2019 Q4 | 830.8 Million SAR | -20.27% |
| 2019 Q3 | 1.04 Billion SAR | 176.97% |
| 2019 Q2 | 376.21 Million SAR | -52.33% |
| 2018 Q1 | 47.2 Million SAR | 152.99% |
| 2018 FY | 3.65 Billion SAR | 4204.56% |
| 2018 Q2 | 22.78 Million SAR | -51.73% |
| 2018 Q3 | 119.05 Million SAR | 422.45% |
| 2018 Q4 | 3.65 Billion SAR | 2971.42% |
| 2017 Q3 | -175.68 Million SAR | -240.98% |
| 2017 Q1 | -186.87 Million SAR | 42.69% |
| 2017 FY | -89.08 Million SAR | 72.68% |
| 2017 Q4 | -89.08 Million SAR | 49.29% |
| 2017 Q2 | -51.52 Million SAR | 72.43% |
| 2016 Q3 | 824.76 Million SAR | 28.63% |
| 2016 Q2 | 641.18 Million SAR | 179.4% |
| 2016 Q1 | 229.48 Million SAR | 401.44% |
| 2016 FY | -326.06 Million SAR | -812.47% |
| 2016 Q4 | -326.06 Million SAR | -139.53% |
| 2015 Q3 | -83.86 Million SAR | -4.16% |
| 2015 FY | 45.76 Million SAR | 138.27% |
| 2015 Q4 | 45.76 Million SAR | 154.57% |
| 2015 Q2 | -80.52 Million SAR | -189.71% |
| 2015 Q1 | -27.79 Million SAR | 76.76% |
| 2014 FY | -119.57 Million SAR | -21.11% |
| 2014 Q4 | -119.57 Million SAR | -3620.81% |
| 2014 Q3 | 3.39 Million SAR | -78.56% |
| 2014 Q2 | 15.84 Million SAR | 129.93% |
| 2014 Q1 | -52.94 Million SAR | 46.38% |
| 2013 Q4 | -98.73 Million SAR | -727.81% |
| 2013 FY | -98.73 Million SAR | 40.57% |
| 2013 Q1 | -70.96 Million SAR | 51.44% |
| 2013 Q2 | 169.93 Thousand SAR | 100.24% |
| 2013 Q3 | 15.72 Million SAR | 9154.85% |
| 2012 Q4 | -146.13 Million SAR | -163.91% |
| 2012 FY | -166.13 Million SAR | 44.18% |
| 2012 Q3 | -55.37 Million SAR | 0.0% |
| 2011 FY | -297.63 Million SAR | 14.27% |
| 2010 FY | -347.17 Million SAR | -225.61% |
| 2009 FY | -106.62 Million SAR | -70.12% |
| 2008 FY | -62.67 Million SAR | 63.2% |
| 2007 FY | -170.32 Million SAR | -30.35% |
| 2006 FY | -130.66 Million SAR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Jamjoom Pharmaceuticals Factory Company | -281.87 Million SAR | 433.48% |